Background and purpose: Current models for the prediction of late patient-rated moderate-to-severe xerostomia (XER 12m ) and sticky saliva (STIC 12m ) after radiotherapy are based on dose-volume parameters and baseline xerostomia (XER base ) or sticky saliva (STIC base ) scores. The purpose is to improve prediction of XER 12m and STIC 12m with patient-specific characteristics, based on CT image biomarkers (IBMs). Methods: Planning CT-scans and patient-rated outcome measures were prospectively collected for 249 head and neck cancer patients treated with definitive radiotherapy with or without systemic treatment. The potential IBMs represent geometric, CT intensity and textural characteristics of the parotid and submandibular glands. Lasso regularisation was used to create multivariable logistic regression models, which were internally validated by bootstrapping. Results: The prediction of XER 12m could be improved significantly by adding the IBM ''Short Run Emphasis" (SRE), which quantifies heterogeneity of parotid tissue, to a model with mean contra-lateral parotid gland dose and XER base . For STIC 12m , the IBM maximum CT intensity of the submandibular gland was selected in addition to STIC base and mean dose to submandibular glands. Conclusion: Prediction of XER 12m and STIC 12m was improved by including IBMs representing heterogeneity and density of the salivary glands, respectively. These IBMs could guide additional research to the patient-specific response of healthy tissue to radiation dose.
The survival of head and neck cancer (HNC) patients has improved remarkably in the last decade with the addition of systemic agents, including concurrent chemotherapy and cetuximab [1, 2] . However, these treatment strategies have significantly increased acute and late toxicity [3] . Consequently, reducing treatment-induced side effects has become increasingly important. Despite the clinical introduction of more advanced radiation techniques, side effects related to hyposalivation, such as xerostomia and sticky saliva, are still frequently reported following radiotherapy (RT) for HNC. Accurate prediction of these side effects is important in order to individually tailor treatments to patients.
To predict moderate-to-severe xerostomia and sticky saliva, Normal Tissue Complication Probability (NTCP) models have been developed [4, 5] . Current models are based on a combination of dose-volume parameters of salivary glands and baseline risk factors. However, these models cannot completely explain the variation in development of xerostomia between individuals. Therefore, identification of additional factors is needed to explain the patient-specific response to dose, and subsequently to optimise NTCP models.
In current clinical practice, three-dimensional anatomic information is acquired with planning CT scans for all patients receiving RT. These scans are used to delineate the target and organs at risk, and to calculate the dose distribution of the planned treatment. These scans yield reproducible information about patient-specific anatomy and tissue composition, and could therefore contribute to the understanding and prediction of the development of side effects in HNC patients.
Information about the structure, shape and composition of organs at risk from the CT can be quantified with image features. Features that correlate with treatment outcome or complications can be used as so called image biomarkers (IBMs). Extracted from CT data of the parotid (PG) and submandibular glands (SG), the different image features represent their CT intensity as well as geometric and textural characteristics.
Aerts et al. [6] investigated the relationship between CT IBMs of head and neck tumours and survival. Furthermore, the relationship between geometric changes of organs at risk after RT, and radiation induced complications, has been described in several studies [7] [8] [9] [10] . Scalco et al. [11] investigated change after RT for a selected set of textural parameters. However, there are no studies so far that report on the relationship between IBMs of organs at risk before treatment and the risk of complications.
The aim of this study, therefore, was to investigate the prediction of xerostomia and sticky saliva, as assessed at 12 months after radiotherapy. The objective was to improve predictions by the addition of IBMs of the parotid and submandibular glands, determined from the planning CT-scans, to models that contain clinical and dosimetric information.
Method

Patient demographics and treatment
The study population of HNC patients was treated with definitive radiotherapy either in combination or not with concurrent chemotherapy or cetuximab, between July 2007 and August 2014. Patients with tumours in the salivary glands, those with excised parotid or submandibular glands and/or patients that underwent surgery in the head and neck area were excluded from this study. Furthermore, patients with metal streaking artifacts in the CT were excluded, due to the influence of CT intensity values that do not correspond to tissue densities. Moreover, patients without follow-up data 12 months after RT were also excluded. Patient characteristics are depicted in Table 1 .
For each patient, a planning CT (Somatom Sensation Open, Siemens, Forchheim, Germany, voxel size: 0.94 Â 0.94 Â 2.0 mm 3 ; 100-140 kV) with contrast enhancement was acquired. This CT was used for contouring and RT planning. The parotid and submandibular glands were delineated according to guidelines as described by Brouwer et al. [12] .
Most patients were treated with standard parotid sparing IMRT (ST-IMRT) or swallowing sparing IMRT (SW-IMRT) [13, 14] . All IMRT and VMAT treatments included a simultaneous integrated boost (SIB) and attempted to spare the parotid glands and/or the swallowing structures without compromising the dose to the target volumes [15] . The tumour and, if present, pathological lymph node target volumes, received a total dose of 70 Gy (2 Gy per fraction). Most patients received an elective radiation dose of 54.25 Gy (1.55 Gy per fraction) on the lymph node levels that were delineated as described by Gregoire et al. [16] . Radiation protocols were similar to those described by Christianen et al. [17] .
Endpoints
The EORTC QLQ-H&N35 questionnaire was used to evaluate patient-rated xerostomia and sticky saliva before and after RT. This questionnaire is part of a standard follow-up programme (SFP), as described in previous reports [4, 18, 19] , and uses a 4-point Likert scale that describes the condition as 'none', 'a bit', 'quite a bit' and 'a lot'. All patients included were subjected to the SFP programme, where toxicity and quality of life were evaluated prospectively on a routine basis; before, during and after treatment.
The endpoints of this study are moderate-to-severe xerostomia (XER 12m ) and sticky saliva (STIC 12m ) 12 month after RT. This corresponds to the 2 highest scores on the 4-point Likert scale.
Potential CT image biomarkers, dose and clinical parameters
Dose and clinical parameters
The planning CT, dose distribution and delineated structures were analysed in Matlab (version R2014a). The mean dose to both the contra-and bi-lateral parotid and submandibular glands was determined, since previous studies have shown that those were the most important parameters in the prediction of patient-rated xerostomia and sticky saliva at 6 and 12 months after RT [4, 5, 20] .
Furthermore, different patient characteristics (age, sex, WHOstage, weight, length and Body Mass Index), tumour characteristics (TNM stage, tumour location) and treatment characteristics (treatment technique and the use of systemic treatment) were also included. In addition, the patient-rated xerostomia and sticky saliva at baseline were taken into account.
CT intensity and geometric image biomarkers
Patient-specific characteristics of the parotid and submandibular glands were quantified by extracting potential CT IBMs, representing geometric, CT-intensity and pattern characteristics. In Fig. 1 , extraction of different types of IBMs is explained schematically. The in-house developed software that was used to extract the IBMs was based on commonly used formulas (Supplementary data 1 and 2) and implemented in Matlab (version R2014a). The CT intensity IBMs (number = 24) were derived from the CT intensity information of the delineated volumes of interest. Examples of these features are mean, variance, minimum, maximum, quantiles, energy and skewness of CT intensity. The geometric IBMs (number = 20), such as volume, sphericity, compactness and major and minor axis length, were directly derived from the delineated structures. 
Textural image biomarkers
More complex CT IBMs are defined to describe the heterogeneity of tissue. These textural IBMs (number = 86) were derived from the grey level co-occurrence matrix (GLCM) [21] , grey level runlength matrix (GLRLM) [22] and grey level size-zone matrix (GLSZM) [23] . To extract this, the CT intensities were binned from À200 to 200 Hounsfield Units (HU) with an interval of 25 HU. All textural features were normalised by subtracting the IBM values from their mean and dividing by the standard deviation. For more information on textural IBM extraction, refer to Supplementary data 2 and Aerts et al. [6] . Ultimately, all potential CT IBMs and clinical and dosimetric parameters together resulted in 142 variables.
Pre-selection of variables and univariable analysis
A large number of potential variables can increase the risk of false positives, overfitting the model and of multicollinearity [24, 25] . In this study, a method for pre-selecting variables was applied to reduce the probability of these adverse effects. First, the (Pearson) correlation was determined between all combinations of variables. If a correlation larger than 0.80 was observed, then the variable with the lowest univariable correlation with the endpoint was omitted. After pre-selection, univariable analysis of the pre-selected variables was performed.
Multivariable analysis and model performance
Lasso regularisation was used to create two multivariable logistic regression models to predict moderate-to-severe XER 12m and STIC 12m . All pre-selected variables were introduced to the modelling process. By increasing the penalisation term lambda, the regularisation shrinks the coefficients of the variables and thereby excludes variables by reducing them to zero. To robustly determine the optimal lambda that results in a model that best fits the observed data, 10-fold cross validation was used [26] . This was repeated 100 times, as these folds are randomly picked [26] .
In general, lasso tends to select models with too many variables [27] . Therefore, the 75th quartile (not the average) of the 100 obtained optimal lambdas was used to select the variables [28] . Subsequently, the variables selected by lasso were again fitted to the data with logistic regression and internally validated through bootstrapping. This validation corrects for optimism by shrinking the model (slope and intercept) and the model performance accordingly [25, 29] .
Reference models without IBMs were created and the contribution of IBMs to the models was tested with the Likelihood-ratio test. The model's performance was quantified in terms of discrimination with the Area Under the Curve of the ROC curve (AUC), the Nagelkerke R 2 and the discrimination slope. The Hosmer-Lemeshow test evaluated the calibration. Variance Inflation Factor (VIF) was used to evaluate the correlation of a variable with all others in the model [30] . The R-packages Lasso and Elastic-Net Regularized Generalized Linear Models (version 2.0-2) [26] and Regression Modeling Strategies (version 4.3-1) [31] were used.
Impact of variation in delineation
Delineation of organs at risk in the head and neck region by different observers may be subject to inter-observer variability [32] , which could result in a variation in IBM values. To evaluate this, four additional delineations per gland per patient were created by eroding the original delineation by magnitudes corresponding to the variations in delineation reported by Brouwer et al. [32] . The IBM stability was evaluated combining the intra-class correlation of the IBM values of the original and created delineations. An IBM with an intra-class correlation higher than 0.70 was considered relatively stable (1.0 indicates identical observations). For more details, refer to Supplementary data 3. 
Results
Patients
After exclusion of patients with metal artefacts in the CT-scans, 424 of the 629 patients (67%) were included. Of the remaining patients, 249 (39%) completed the EORTC QLQ-HN35 at 12 months after treatment and were included in the analysis. Moderate-tosevere xerostomia was reported in 40% (100) and sticky saliva in 25% (63) of these patients.
Pre-selecting variables and univariable analysis
After testing of inter-variable correlation (Pearson), a selection of 26 of 142 variables for XER 12m and 24 of 142 variables for STIC 12m were pre-selected. Univariable analysis of the preselected variables showed that 8 and 6 variables were significantly correlated to XER 12m and STIC 12m, respectively (p-value < 0.05) ( Table 2 ). However, all pre-selected variables were used in the lasso regularisation process. These pre-selected variables are listed in the Supplementary data 4.
Multivariable analysis and model performance
For Xer 12m , the variables selected by the lasso modelling process were mean dose to the contra-lateral parotid gland, baseline xerostomia and the image biomarker ''Short Run Emphasis" (SRE). The SRE significantly improved the model in terms of overall and discrimination performance (Likelihood Ratio test: p = 0.01). The AUC increased from 0.75 (0.69-0.81) to 0.77 (0.71-0.82) and the discrimination slope from 0.19 to 0.21.
For STIC 12m , the mean dose of both submandibular glands, baseline sticky saliva, the maximum CT intensity and Short Run High Gray Emphasis (SRHGE) were selected. The maximum CT intensity added significantly to the model (Likelihood Ratio test, p = 0.005). However, the SRHGE did not improve the model performance significantly (Likelihood-ratio test, p = 0.12) and had negligible effect on the AUC. Therefore, the variable SRHGE was discarded from further analysis and only the maximum intensity was used. Adding this IBM to the mean dose and baseline sticky saliva based model improved the discrimination slope of the model (from 0.15 to 0.18) and the AUC (from 0.74 (0.67-0.80) to 0.77 (0.71-0.83), from 0.73 to 0.76 when tested in bootstrapped data). Resulting (corrected) coefficients and performance measures of the models are depicted in Tables 3 and 4 , respectively. For the formulas of the final models refer to Supplementary data 5.
The Hosmer-Lemeshow test showed that calibration was satisfactory for all models (Table 4) , indicating a good agreement between the predicted and observed patient outcomes. Additionally, the variance inflation factor (VIF) of all selected variables was <1.03, indicating low correlation.
Impact of variation in delineation
For all 249 patients, 4 extra delineations were created of both the contra-lateral parotid and submandibular gland. IBMs were extracted from all delineations. Their robustness was determined with the intra-class correlation (>0.70). For the parotid gland, 92 of all 130 IBMs (71%) were robust. For the submandibular gland, 73 IBMs (56%) were robust. The intra-class correlation of the SRE (IBM in final model Xer 12m ) was 0.85 (95% CI; 0.82-0.87), indicating that this IBM was relatively robust for contour variations. The maximum intensity of the submandibular gland (IBM in final model STIC 12m ) was more sensitive for contour variation with an ICC of 0.70 (95% CI; 0.66-0.75).
Discussion
The results of this study showed that prediction of XER 12m and STIC 12m could be significantly improved by adding the IBMs Short Run Emphasis (SRE) of the parotid gland and maximum CT intensity of the submandibular gland to the reference models based on dose-volume parameters and baseline factors. The improvements of both models with IBMs persisted when internally validated with both lasso regularisation and bootstrapping. These models with IBMs are a first step to understanding the patientspecific response of healthy tissue to dose. This could contribute to a better prediction of side effects and selection of patients, based on these predictions for advanced treatment techniques, as proposed by Langendijk et al. with the model-based approach to select patients for proton therapy [33] .
Short Run Emphasis (SRE) and xerostomia
The SRE obtained from the GLRLM matrix, was associated with the development of XER 12m . This IBM is related to the occurrence of short lengths of similar CT intensity value repetitions within the contour. High SRE values indicate heterogeneous parotid tissue or, in other words, that the parotid gland parenchyma is irregular in these patients. Visual investigation of the parotid glands of several patients with high and low SRE suggested that this irregularity resulted from fat saturation of parotid glands ( Fig. 2A-D) . The relationship between fat saturation and impaired parotid function has been shown by Izumi et al. [34] for patients with xerostomia related diseases: Sjögren's syndrome and hyperlipidemia. Apparently, the ratio between fatty tissue and functional parotid parenchyma tissue is related to parotid function. Our results suggest that patients with a larger ratio of fat to parotid parenchyma tissue in the parotid glands have a larger risk of developing radiationinduced xerostomia. Our results suggest that patient-specific risk of developing radiation-induced xerostomia can be quantified by IBMs, a first step to explaining the patient-specific response in developing xerostomia to dose. However, CT is not the most optimal image modality to differentiate fat and gland parenchyma.
Since MRI is superior in differentiating fat and gland tissue, evaluating parotid glands prior to treatment using MRI images could provide better information for predicting XER 12m [35] . Some studies have found a relationship between the initial size of the parotid gland and function prior to [34] and after RT [10, 36] . We could not reproduce this in our population. Only a univariable significant association was found between the volume of the surrounding bounding box of the parotid gland and XER 12m .
Maximum intensity and sticky saliva
Our multivariable analysis showed that the maximum CT intensity value of the submandibular gland was associated with STIC 12m . This maximum CT intensity was related to intra-vascular contrast in the artery or vein supplying the submandibular gland ( Fig. 2E  and F) . There are no studies reported that support our finding that there is a relationship between vascularisation of the submandibular gland and the development of sticky saliva. Both lasso and internal bootstrapped validation showed robust improvement of prediction with the maximum intensity. However, this IBM was not very stable for the inter-observer variation in delineations of the submandibular glands. Since the blood vessels supplying the submandibular gland can be located at the border of the gland, they are not always delineated, resulting in this marginal stability. Additionally, we expect that the timing of, or the absence of intravenous contrast admitted during acquisition will have a big impact on this IBM. This IBM seems, therefore, suboptimal and further research is necessary to investigate whether there is an underlying mechanism. For example, higher perfusion could relate to higher oxidation of the submandibular gland, thus increasing the radio-sensitivity. Furthermore, the significant improvement of the prediction of STIC 12m by the maximum CT intensity of the submandibular gland should be tested in an external dataset.
Robustness of modeling
The risk of finding false positive associations and overfitting the model were partly addressed by pre-selecting variables based on their inter-correlation. Additionally, we performed alternative multivariable analyses, including logistic regression with forward and backward variable selection based on log-likelihood and the Akaike information criterion (AIC), respectively. The dominating factors selected by these analyses were the same as selected by the lasso regularisation. The same was true if forward selection was performed without pre-selection. Therefore, the selected variables were independent of the method of analysis. This suggests the stability of the associations in this dataset are relatively high. Furthermore, coefficients and performance measures of all models were corrected for optimism by means of internal validation. However, the model selection procedure was not included in the internal validation, as this inhibited model comparison, and so further external validation is warranted.
Clinical impact
In this study it was shown that the NTCP models based on dose and baseline complaints were significantly improved with IBMs. Nevertheless, the clinical impact of the model improvement in terms of classification and performance remains limited at this point in time. Yet we consider the current study important, as it is an initial step to improve understanding of the patient-specific response of healthy tissue to RT, hereby leading to better identification of HNC patients at risk of developing side effects.
Conclusion
Prediction of xerostomia and sticky saliva 12 months after RT was significantly improved by including CT characteristics of the parotid and submandibular glands for our patient group. The CT image biomarker that positively associated with higher probability of developing xerostomia was ''Short Run Emphasis", which might be a measure of non-functional fatty parotid tissue. The maximum CT intensity in the submandibular glands was associated with sticky saliva, and probably related with vascularisation. These image biomarkers are a first step to identifying patient characteristics that explain the patient-specific response of healthy tissue to dose.
